Court Overseeing Federal Testosterone Treatment Lawsuits to Address Coordination of State, Federal Claims, Bernstein Liebhard LLP Reports

Share Article

The Firm is evaluating testosterone lawsuits on behalf of men who suffered serious cardiovascular complications allegedly due to their use of AndroGel and other low testosterone therapies.

Free Case Review
Our Firm continues to receive inquiries from men who allegedly suffered heart attacks, strokes, blood clots and other life-threatening heart problems due to their use of testosterone replacement drugs.

Testosterone treatment lawsuits ( that allege the use of AndroGel and similar drugs can increase the risk of heart attacks, strokes and other serious cardiovascular complications continue to move forward in state and federal courts, Bernstein Liebhard LLP reports. According to a Joint Status Report filed on December 4th, the Court overseeing the federal testosterone litigation underway in the U.S. District Court, Northern District of Illinois, will meet today to discuss ways in which claims pending in state courts may be coordinated with those filed in the federal proceeding. A Joint Agenda submitted on December 4th indicates that the Court will also address status of discovery, document production, and depositions during today’s Conference. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm continues to receive inquiries from men who allegedly suffered heart attacks, strokes, blood clots and other life-threatening heart problems due to their use of testosterone replacement drugs. We are pleased to see that the federal litigation is moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now evaluating legal claims on behalf of men who were allegedly harmed by AndroGel and other testosterone treatments.

Testosterone Treatment Litigation
According to court documents, nearly 260 testosterone treatment lawsuits are now pending in the federal litigation underway in the Northern District of Illinois. The proceeding was established over the summer, following the U.S. Food & Drug Administration’s (FDA) January announcement that it was investigating the cardiovascular risks associated with low testosterone therapy. Since then, a panel of FDA advisors recommended that the drugs’ labels be revised to make clear they have not been shown to lessen low libido, fatigue, muscle loss and other age-related symptoms. They also recommended that the manufacturers of testosterone replacement therapies be required to conduct studies of their cardiovascular side effects.*

All of the testosterone lawsuits pending in Illinois allege that testosterone replacement drugs are associated with an increased risk of heart attack, stroke and other life-threatening cardiovascular events. Among other things, the complaints claim that the manufacturers of low testosterone therapies failed to warn doctors and patients about their potential risks, and concealed those dangers from the public. Plaintiffs further allege that sales of testosterone replacement products were driven by deceptive marketing tactics that induced many healthy men to use the drugs in the absence of a true medical need.

Men who allegedly suffered heart attacks, stroke, deep vein thrombosis, pulmonary embolism or other serious cardiovascular problems due to their use of prescription testosterone therapies may be entitled to join this growing litigation. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*, Reuters, September 18, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website